229 related articles for article (PubMed ID: 22306274)
1. Interpretation of point-of-care INR results in patients treated with dabigatran.
van Ryn J; Baruch L; Clemens A
Am J Med; 2012 Apr; 125(4):417-20. PubMed ID: 22306274
[TBL] [Abstract][Full Text] [Related]
2. Potential inaccuracy of point-of-care INR in dabigatran-treated patients.
Baruch L; Sherman O
Ann Pharmacother; 2011 Jul; 45(7-8):e40. PubMed ID: 21712509
[TBL] [Abstract][Full Text] [Related]
3. Inaccuracy of point-of-care international normalized ratio in rivaroxaban-treated patients.
Baruch L; Sherman O
Ann Pharmacother; 2013 Sep; 47(9):1210-2. PubMed ID: 24259738
[TBL] [Abstract][Full Text] [Related]
4. Dabigatran and atrial fibrillation: the alternative to warfarin for selected patients.
Prescrire Int; 2012 Feb; 21(124):33-6. PubMed ID: 22413715
[TBL] [Abstract][Full Text] [Related]
5. Dabigatran: an oral direct thrombin inhibitor for use in atrial fibrillation.
Bendel SD; Bona R; Baker WL
Adv Ther; 2011 Jun; 28(6):460-72. PubMed ID: 21533567
[TBL] [Abstract][Full Text] [Related]
6. Point-of-care testing of the international normalized ratio in patients with antiphospholipid antibodies.
Perry SL; Samsa GP; Ortel TL
Thromb Haemost; 2005 Dec; 94(6):1196-202. PubMed ID: 16411394
[TBL] [Abstract][Full Text] [Related]
7. Effects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assays.
Lindahl TL; Baghaei F; Blixter IF; Gustafsson KM; Stigendal L; Sten-Linder M; Strandberg K; Hillarp A;
Thromb Haemost; 2011 Feb; 105(2):371-8. PubMed ID: 21103660
[TBL] [Abstract][Full Text] [Related]
8. [Dabigatran therapy--perioperative management and interpretation of coagulation tests].
Spannagl M; Bauersachs R; Debus ES; Gawaz M; Gerlach H; Haas S; Hach-Wunderle V; Lindhoff-Last E; Riess H; Schellong S; Schinzel H; Bode C
Hamostaseologie; 2012; 32(4):294-305. PubMed ID: 23114798
[TBL] [Abstract][Full Text] [Related]
9. Rectal bleeding and hemostatic disorders induced by dabigatran etexilate in 2 elderly patients.
Béné J; Saïd W; Rannou M; Deheul S; Coupe P; Gautier S
Ann Pharmacother; 2012 Jun; 46(6):e14. PubMed ID: 22669799
[TBL] [Abstract][Full Text] [Related]
10. Dabigatran falsely elevates point of care international normalized ratio results.
DeRemer CE; Gujral JS; Thornton JW; Sorrentino RA
Am J Med; 2011 Sep; 124(9):e5-6. PubMed ID: 21640327
[No Abstract] [Full Text] [Related]
11. Evaluating and assessing dabigatran drug interactions.
Nguyen T; Wong E
Consult Pharm; 2012 Jul; 27(7):509-12. PubMed ID: 22910132
[TBL] [Abstract][Full Text] [Related]
12. Quality assurance program for whole blood prothrombin time-international normalized ratio point-of-care monitors used for patient self-testing to control oral anticoagulation.
Tripodi A; Bressi C; Carpenedo M; Chantarangkul V; Clerici M; Mannucci PM
Thromb Res; 2004; 113(1):35-40. PubMed ID: 15081563
[TBL] [Abstract][Full Text] [Related]
13. Striking a balance between the risks and benefits of anticoagulation bridge therapy in patients with atrial fibrillation: clinical updates and remaining controversies.
Garwood CL; Hwang JM; Moser LR
Pharmacotherapy; 2011 Dec; 31(12):1208-20. PubMed ID: 22122182
[TBL] [Abstract][Full Text] [Related]
14. Dabigatran: life-threatening bleeding.
Prescrire Int; 2013 Feb; 22(135):41-3. PubMed ID: 23444501
[TBL] [Abstract][Full Text] [Related]
15. Atrial fibrillation and dabigatran: has the time come to use new anticoagulants?
Escobar C; Barrios V; Jimenez D
Cardiovasc Ther; 2010 Oct; 28(5):295-301. PubMed ID: 20718760
[TBL] [Abstract][Full Text] [Related]
16. Fatal gastrointestinal hemorrhage after a single dose of dabigatran.
Kernan L; Ito S; Shirazi F; Boesen K
Clin Toxicol (Phila); 2012 Aug; 50(7):571-3. PubMed ID: 22800505
[TBL] [Abstract][Full Text] [Related]
17. The reliability of point-of-care prothrombin time testing. A comparison of CoaguChek S and XS INR measurements with hospital laboratory monitoring.
Ryan F; O'Shea S; Byrne S
Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e26-33. PubMed ID: 19032373
[TBL] [Abstract][Full Text] [Related]
18. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P
Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
[TBL] [Abstract][Full Text] [Related]
19. Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of long-term anticoagulant therapy (RE-LY) trial.
Eikelboom JW; Wallentin L; Connolly SJ; Ezekowitz M; Healey JS; Oldgren J; Yang S; Alings M; Kaatz S; Hohnloser SH; Diener HC; Franzosi MG; Huber K; Reilly P; Varrone J; Yusuf S
Circulation; 2011 May; 123(21):2363-72. PubMed ID: 21576658
[TBL] [Abstract][Full Text] [Related]
20. Dabigatran-induced gastrointestinal bleeding in an elderly patient with moderate renal impairment.
Wychowski MK; Kouides PA
Ann Pharmacother; 2012 Apr; 46(4):e10. PubMed ID: 22496474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
